Also, we have shown that inhibition MKK4, an upstream activator of HSP27, by small molecule therapeutics decreases MMP-2, inhibits cell invasion, and inhibits human PCa cell metastasis in pre-clinical studies [11, 12, 33]. The gene discussed is MMP2; the disease is posterior cortical atrophy.